Q-1802OxaliplatinXELOXcapecitabinePeking University Cancer Hospitaladvanced GC/GEJ
…. Patients with untreated advanced GC/GEJ are administered with Q-1802 (IV, Q2W) respectively at 10 mg/kg and 20 mg/kg dose level in c…
40articles mentioning drugs
71drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Oxaliplatin ×
Oxaliplatin
This drug is selected. Its supporting articles are shown below.
Articles mentioning Oxaliplatin
40 articles · page 4 of 4liposomal doxorubicinoxaliplatincombretastatin A4 PhosphateCA4PacPD-1Hospital Oncológico Veterinario La RiojaNational Autonomous University of MexicohTCCanine thyroid carcinomas (CTCs)CFTC
…orm. Under US-IT each tumor mass was treated on day 0 (D0) with liposomal doxorubicin, oxaliplatin, and combretastatin A4 Phosphate (CA4P) (0.125 mg,…
trastuzumabzoledronic acidlapatinibabirateroneoxaliplatinCancer drugsimmunotherapeutic agentsrenal cell carcinomabreast cancercolon cancer+5 more
…vant therapy for oxaliplatin in colon cancer or the duration of trastuzumab in breast cancer, FDA labels are not regularly updated,25 and t…
pembrolizumabcapecitabinezolbetuximaboxaliplatingastric cancerNCT04249739
…st-line chemotherapy (capecitabine/oxaliplatin) with sequential pembrolizumab. CLDN18.2 expression was assessed by immunohistochemistry, and …